VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $335,717 | -26.7% | 25,318 | +3.7% | 0.00% | -33.3% |
| Q2 2023 | $457,838 | +40.7% | 24,418 | +8.2% | 0.00% | +50.0% |
| Q1 2023 | $325,431 | -24.0% | 22,568 | +2.0% | 0.00% | -33.3% |
| Q4 2022 | $428,003 | -42.3% | 22,119 | +2.4% | 0.00% | -40.0% |
| Q3 2022 | $742,000 | +181.1% | 21,601 | +24.9% | 0.01% | +150.0% |
| Q2 2022 | $264,000 | -36.1% | 17,288 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $413,000 | +33.2% | 18,095 | +115.5% | 0.00% | 0.0% |
| Q4 2021 | $310,000 | -23.6% | 8,397 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | – | 8,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |